Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemia and Septic Shock

NCT01046669 is registered in ClinicalTrials.gov with Spectral Diagnostics (US) Inc. as lead sponsor.

NCT NCT01046669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01046669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemia and Septic Shock
Lead sponsor
Spectral Diagnostics (US) Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2017
Enrollment
450 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

endotoxemia, septic shock